Literature DB >> 6286121

Platinum concentrations in human glioblastoma multiforme following the use of cisplatin.

E M Bonnem, C L Litterst, F P Smith.   

Abstract

A 24-year-old female with glioblastoma multiforme was not given a nitrosourea because of interstitial lung disease. Cisplatin was administered monthly for five cycles until disease progression. A second debulking procedure was performed and tumor tissue assayed for the presence of platinum. Levels were measurable 7 weeks after the course of treatment.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6286121

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


  8 in total

Review 1.  Do anticancer agents reach the tumor target in the human brain?

Authors:  M G Donelli; M Zucchetti; M D'Incalci
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

2.  Platinum concentration in human tumors of head and neck, uterine cervix, and breast following treatment with cisplatin.

Authors:  B Hecquet; P Vennin; C Fournier; J L Lefebvre; A Caty; J Bonneterre; L Adenis; A Demaille
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

Review 3.  A critique of the role of the blood-brain barrier in the chemotherapy of human brain tumors.

Authors:  D J Stewart
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

4.  Intra-arterial cisplatin in malignant brain tumors: incidence and severity of otic toxicity.

Authors:  R Assietti; J J Olson
Journal:  J Neurooncol       Date:  1996-03       Impact factor: 4.130

Review 5.  The role of chemotherapy in the treatment of patients with brain metastases from solid tumors.

Authors:  J C Buckner
Journal:  Cancer Metastasis Rev       Date:  1991-12       Impact factor: 9.264

6.  cis-diamminedichloroplatinum (CDDP) therapy for brain metastasis of lung cancer. I. Distribution within the central nervous system after intravenous and intracarotid infusion.

Authors:  H Nakagawa; T Fujita; S Izumoto; S Kubo; Y Nakajima; K Tsuruzono; K Kodama; M Higashiyama; O Doi; T Hayakawa
Journal:  J Neurooncol       Date:  1993-04       Impact factor: 4.130

7.  Alterations in plasma pharmacokinetics of cisplatin in tumor-bearing rats.

Authors:  C L Litterst; R Magin
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

8.  Cerebral herniation in patients receiving cisplatin.

Authors:  R W Walker; J G Cairncross; J B Posner
Journal:  J Neurooncol       Date:  1988       Impact factor: 4.130
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.